CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
首页Home / 产品查询Product Search / 按品种找对照品By drug substance / 琥珀酸索利那新Solifenacin Succinate
Solifenacin Succinate

琥珀酸索利那新 杂质对照品Solifenacin Succinate Impurities

EP48 个杂质条目48 impurity entries

本页汇总 琥珀酸索利那新 的 48 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 48 impurity reference standards of Solifenacin Succinate with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 琥珀酸索利那新(Solifenacin Succinate)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesValidated comprehensive RP HPLC approach for separation and quantification of solifenacin and mirabegron in the presence of their degradation products
    Scientific reports · 2026 · Kamel EB et al.  ·  PMID 41826414  ·  DOI
  2. 杂质研究Impurity studiesFacile Access to Solifenacin Impurity K: One-Step Synthesis and an HPLC-MS Method for Its Determination
    Molecules (Basel, Switzerland) · 2024 · Xifra R et al.  ·  PMID 38998963  ·  DOI
  3. 杂质研究Impurity studiesA validated rapid stability-indicating method for the determination of related substances in solifenacin succinate by ultra-fast liquid chromatography
    Journal of chromatographic science · 2010 · Krishna SR et al.  ·  PMID 21044410  ·  DOI
  4. 分析方法Analytical MethodsA High-Throughput LC-MS/MS Bioanalytical Method for Simultaneous Determination of Mirabegron and Solifenacin in Pharmacokinetic Investigations
    Biomedical chromatography : BMC · 2026 · Tungapati S et al.  ·  PMID 41983904  ·  DOI
  5. 分析方法Analytical MethodsCentral Composite Design Assisted Spectrofluorimetric Determination of Solifenacin via Quenching of Acid Red 51: Application in Pharmaceutical Formulations and Plasma
    Luminescence : the journal of biological and chemical luminescence · 2025 · Alqahtani A et al.  ·  PMID 40858523  ·  DOI

琥珀酸索利那新 —— 原料药与杂质对照品Solifenacin Succinate — drug substance & impurities

共 48 个条目(含原料药本体)48 items incl. the drug substance
Solifenacin Succinate structure
EP原料药 APIAPI
琥珀酸索利那新Solifenacin Succinate
Solifenacin Succinate
CAS No.242478-38-2
Chemical FormulaC23H26N2O2·C4H6O4
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 20(Solifenacin Succinate EP Impurity A) structure
EPA
琥珀酸索利那新杂质20(琥珀酸索利那新EP杂质A)Solifenacin Succinate Impurity 20(Solifenacin Succinate EP Impurity A)
Solifenacin Succinate Impurity 20(Solifenacin Succinate EP Impurity A)
CAS No.118864-75-8
Chemical FormulaC15H15N
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 3 (Solifenacin Succinate EP Impurity B) structure
EPB
琥珀酸索利那新杂质3 (琥珀酸索利那新EP杂质B)Solifenacin Succinate Impurity 3 (Solifenacin Succinate EP Impurity B)
Solifenacin Succinate Impurity 3 (Solifenacin Succinate EP Impurity B)
CAS No.1353274-25-5
Chemical FormulaC19H21NO2
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 9 (Solifenacin Succinate EP Impurity C) structure
EPC
琥珀酸索利那新杂质9 (琥珀酸索利那新EP杂质C)Solifenacin Succinate Impurity 9 (Solifenacin Succinate EP Impurity C)
Solifenacin Succinate Impurity 9 (Solifenacin Succinate EP Impurity C)
CAS No.1534326-81-2
Chemical FormulaC31H28N2O
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 7 (Solifenacin Succinate EP Impurity D) structure
EPD
琥珀酸索利那新杂质7 (琥珀酸索利那新EP杂质D)Solifenacin Succinate Impurity 7 (Solifenacin Succinate EP Impurity D)
Solifenacin Succinate Impurity 7 (Solifenacin Succinate EP Impurity D)
CAS No.2216750-52-4
Chemical FormulaC31H28N2O
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 21 (Solifenacin Succinate EP Impurity E) structure
EPE
琥珀酸索利那新杂质21 (琥珀酸索利那新EP杂质E)Solifenacin Succinate Impurity 21 (Solifenacin Succinate EP Impurity E)
Solifenacin Succinate Impurity 21 (Solifenacin Succinate EP Impurity E)
CAS No.25333-42-0
Chemical FormulaC7H13NO
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 6 (Solifenacin Succinate EP Impurity F) structure
EPF
琥珀酸索利那新杂质6 (琥珀酸索利那新EP杂质F)Solifenacin Succinate Impurity 6 (Solifenacin Succinate EP Impurity F)
Solifenacin Succinate Impurity 6 (Solifenacin Succinate EP Impurity F)
CAS No.774517-20-3
Chemical FormulaC23H26N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 5 (Solifenacin Succinate EP Impurity G) structure
EPG
琥珀酸索利那新杂质5 (琥珀酸索利那新EP杂质G)Solifenacin Succinate Impurity 5 (Solifenacin Succinate EP Impurity G)
Solifenacin Succinate Impurity 5 (Solifenacin Succinate EP Impurity G)
CAS No.740780-79-4
Chemical FormulaC23H26N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 4 Hydrochloride (Solifenacin Succinate EP Impurity H Hydrochloride) structure
EPH
琥珀酸索利那新杂质4盐酸盐 (琥珀酸索利那新EP杂质H盐酸盐)Solifenacin Succinate Impurity 4 Hydrochloride (Solifenacin Succinate EP Impurity H Hydrochloride)
Solifenacin Succinate Impurity 4 Hydrochloride (Solifenacin Succinate EP Impurity H Hydrochloride)
CAS No.180468-38-6
Chemical FormulaC23H26N2O2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 4 (Solifenacin Succinate EP Impurity H) structure
EPH
琥珀酸索利那新杂质4 (琥珀酸索利那新EP杂质H)Solifenacin Succinate Impurity 4 (Solifenacin Succinate EP Impurity H)
Solifenacin Succinate Impurity 4 (Solifenacin Succinate EP Impurity H)
CAS No.732228-02-3
Chemical FormulaC23H26N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 1 (Solifenacin Succinate EP Impurity I) structure
EPI
琥珀酸索利那新杂质1 (琥珀酸索利那新EP杂质I)Solifenacin Succinate Impurity 1 (Solifenacin Succinate EP Impurity I)
Solifenacin Succinate Impurity 1 (Solifenacin Succinate EP Impurity I)
CAS No.180272-28-0
Chemical FormulaC23H26N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin-d5 structure
—
索利那新-d5Solifenacin-d5
Solifenacin-d5
CAS No.1401416-00-9
Chemical FormulaC23H21D5N2O2
Purity>95%询价On request
Solifenacin Hydrochloride structure
—
盐酸索利那新Solifenacin Hydrochloride
Solifenacin Hydrochloride
CAS No.180468-39-7
Chemical FormulaC23H26N2O2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin structure
—
索利那新Solifenacin
Solifenacin
CAS No.242478-37-1
Chemical FormulaC23H26N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 2 structure
2
琥珀酸索利那新杂质2Solifenacin Succinate Impurity 2
Solifenacin Succinate Impurity 2
CAS No.180272-45-1
Chemical FormulaC15H15N
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 10 structure
10
琥珀酸索利那新杂质10Solifenacin Succinate Impurity 10
Solifenacin Succinate Impurity 10
CAS No.52250-50-7
Chemical FormulaC15H13N
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 12 structure
12
琥珀酸索利那新杂质12Solifenacin Succinate Impurity 12
Solifenacin Succinate Impurity 12
CAS No.180468-42-2
Chemical FormulaC18H19NO2
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 15 structure
15
琥珀酸索利那新杂质15Solifenacin Succinate Impurity 15
Solifenacin Succinate Impurity 15
CAS No.1956436-64-8
Chemical FormulaC23H26N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 16 structure
16
琥珀酸索利那新杂质16Solifenacin Succinate Impurity 16
Solifenacin Succinate Impurity 16
CAS No.134021-15-1
Chemical FormulaC15H13N
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 17 structure
17
琥珀酸索利那新杂质17Solifenacin Succinate Impurity 17
Solifenacin Succinate Impurity 17
CAS No.22990-19-8
Chemical FormulaC15H15N
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 19 structure
19
琥珀酸索利那新杂质19Solifenacin Succinate Impurity 19
Solifenacin Succinate Impurity 19
CAS No.1193-65-3
Chemical FormulaC7H11NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 22 structure
22
琥珀酸索利那新杂质22Solifenacin Succinate Impurity 22
Solifenacin Succinate Impurity 22
CAS No.34583-34-1
Chemical FormulaC7H13NO
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 24 structure
24
琥珀酸索利那新杂质24Solifenacin Succinate Impurity 24
Solifenacin Succinate Impurity 24
CAS No.3278-14-6
Chemical FormulaC15H15NO
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 25 structure
25
琥珀酸索利那新杂质25Solifenacin Succinate Impurity 25
Solifenacin Succinate Impurity 25
CAS No.128311-06-8
Chemical FormulaC15H22N2·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 25 Monomer structure
25
琥珀酸索利那新杂质25 单体Solifenacin Succinate Impurity 25 Monomer
Solifenacin Succinate Impurity 25 Monomer
CAS No.142999-60-8
Chemical FormulaC15H22N2
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 26 structure
26
琥珀酸索利那新杂质26Solifenacin Succinate Impurity 26
Solifenacin Succinate Impurity 26
CAS No.1243274-81-8
Chemical FormulaC14H16N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 28 structure
28
琥珀酸索利那新杂质28Solifenacin Succinate Impurity 28
Solifenacin Succinate Impurity 28
CAS No.96514-03-3
Chemical FormulaC18H34N22+·2Br-
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 29 structure
29
琥珀酸索利那新杂质29Solifenacin Succinate Impurity 29
Solifenacin Succinate Impurity 29
CAS No.187099-22-5
Chemical FormulaC19H36N22+·2Br-
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 31 structure
31
琥珀酸索利那新杂质31Solifenacin Succinate Impurity 31
Solifenacin Succinate Impurity 31
CAS No.1229227-22-8
Chemical FormulaC22H18N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 32 structure
32
琥珀酸索利那新杂质32Solifenacin Succinate Impurity 32
Solifenacin Succinate Impurity 32
CAS No.13929-94-7
Chemical FormulaC7H11N
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 33 structure
33
琥珀酸索利那新杂质33Solifenacin Succinate Impurity 33
Solifenacin Succinate Impurity 33
CAS No.6238-15-9
Chemical FormulaC9H16N2O
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 34 structure
34
琥珀酸索利那新杂质34Solifenacin Succinate Impurity 34
Solifenacin Succinate Impurity 34
CAS No.2407763-28-2
Chemical FormulaC23H26N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 35 structure
35
琥珀酸索利那新杂质35Solifenacin Succinate Impurity 35
Solifenacin Succinate Impurity 35
CAS No.1029430-94-1
Chemical FormulaC19H17N3O
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 36 structure
36
琥珀酸索利那新杂质36Solifenacin Succinate Impurity 36
Solifenacin Succinate Impurity 36
CAS No.1243274-83-0
Chemical FormulaC14H17NO3
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 37 structure
37
琥珀酸索利那新杂质37Solifenacin Succinate Impurity 37
Solifenacin Succinate Impurity 37
CAS No.1422505-78-9
Chemical FormulaC17H17NO
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 38 structure
38
琥珀酸索利那新杂质38Solifenacin Succinate Impurity 38
Solifenacin Succinate Impurity 38
CAS No.1035272-88-8
Chemical FormulaC16H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 39 structure
39
琥珀酸索利那新杂质39Solifenacin Succinate Impurity 39
Solifenacin Succinate Impurity 39
CAS No.605696-10-4
Chemical FormulaC25H30N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 40 structure
40
琥珀酸索利那新杂质40Solifenacin Succinate Impurity 40
Solifenacin Succinate Impurity 40
CAS No.861998-77-8
Chemical FormulaC23H26N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 41 structure
41
琥珀酸索利那新杂质41Solifenacin Succinate Impurity 41
Solifenacin Succinate Impurity 41
CAS No.2407763-27-1
Chemical FormulaC25H30N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 42 structure
42
琥珀酸索利那新杂质42Solifenacin Succinate Impurity 42
Solifenacin Succinate Impurity 42
CAS No.1225338-27-1
Chemical FormulaC23H26N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 43 structure
43
琥珀酸索利那新杂质43Solifenacin Succinate Impurity 43
Solifenacin Succinate Impurity 43
CAS No.1427376-05-3
Chemical FormulaC15H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 44 Dihydrochloride structure
44
琥珀酸索利那新杂质44 双盐酸盐Solifenacin Succinate Impurity 44 Dihydrochloride
Solifenacin Succinate Impurity 44 Dihydrochloride
CAS No.1682642-69-8
Chemical FormulaC15H22N2·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 44 structure
44
琥珀酸索利那新杂质44Solifenacin Succinate Impurity 44
Solifenacin Succinate Impurity 44
CAS No.1682749-15-0
Chemical FormulaC15H22N2
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 45 structure
45
琥珀酸索利那新杂质45Solifenacin Succinate Impurity 45
Solifenacin Succinate Impurity 45
CAS No.1863095-36-6
Chemical FormulaC23H26N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 46 structure
46
琥珀酸索利那新杂质46Solifenacin Succinate Impurity 46
Solifenacin Succinate Impurity 46
CAS No.2748378-02-9
Chemical FormulaC23H26N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 51 structure
51
琥珀酸索利那新杂质51Solifenacin Succinate Impurity 51
Solifenacin Succinate Impurity 51
CAS No.2753060-21-6
Chemical FormulaC18H20N2O
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 53 structure
53
琥珀酸索利那新杂质53Solifenacin Succinate Impurity 53
Solifenacin Succinate Impurity 53
CAS No.1798817-91-0
Chemical FormulaC23H26N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Solifenacin Succinate Impurity 54 structure
54
琥珀酸索利那新杂质54Solifenacin Succinate Impurity 54
Solifenacin Succinate Impurity 54
CAS No.2512210-26-1
Chemical FormulaC22H19NO2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

琥珀酸索利那新 —— 研究文献与合成路线Solifenacin Succinate — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 琥珀酸索利那新 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Solifenacin Succinate. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Expeditive Chromatographic Methods for Quantification of Solifenacin Succinate along with its Official Impurity as the Possible Acid Degradation Product
    Eissa MS, Kamel EB, Hegazy MA, et al. · Journal of chromatographic science · 2023 · 被引 5cited 5
  2. A validated rapid stability-indicating method for the determination of related substances in solifenacin succinate by ultra-fast liquid chromatography
    Krishna SR, Rao BM, Rao NS · Journal of chromatographic science · 2010 · 被引 3cited 3

合成与制备工艺专利Synthesis & process patents

  1. NOVEL PROCESS FOR THE PREPARATION OF SOLIFENACIN SUCCINATE
    KAMAT ANAND GOPALKRISHNA, KOILPILLAI JOSEPH PRABAHAR, GANALA NAGA TRINADHACHARI, UPPUTURI VENKATA LAKSHMI, et al. · 公开号 WO2012001481WO2012001481 · 2012
  2. PROCESS FOR THE PREPARATION OF SOLIFENACIN AND SOLIFENACIN SUCCINATE
    SZRAMKA ROMAN, DRYGAS JERSY, SZULC MARCIN · 公开号 WO2011086003WO2011086003 · 2011
  3. Method of the solifenacin succinate manufacturing
    SZRAMKA ROMAN, DRYGAS JERZY, SZULC MARCIN · 公开号 PL390214PL390214 · 2011
  4. Process for preparing polymorphic forms of solifenacin succinate
    KOLTAI TAMAS, NIDAM TAMAR, GILBOA EYAL, PERLMAN NURIT, et al. · 公开号 US2008114028US2008114028 · 2008
  5. PROCESSES FOR PREPARING POLYMORPHIC FORMS OF SOLIFENACIN SUCCINATE
    KOLTAI TAMAS, NIDAM TAMAR, GILBOA EYAL, PERLMAN NURIT, et al. · 公开号 EP2043639EP2043639 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

琥珀酸索利那新 杂质谱研究要点Solifenacin Succinate — impurity profiling notes

下面这些是拿到 琥珀酸索利那新 的 48 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 48 impurity entries for Solifenacin Succinate, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances